Alphatec Holdings Inc  

(Public, NASDAQ:ATEC)   Watch this stock  
Find more results for Stephen E. O'Neil
0.390
+0.030 (8.33%)
Jul 22 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 0.34 - 0.39
52 week 0.15 - 1.40
Open 0.36
Vol / Avg. 124,514.00/309,919.00
Mkt cap 39.43M
P/E     -
Div/yield     -
EPS -1.82
Shares 102.49M
Beta 1.57
Inst. own 54%
Aug 18, 2016
Alphatec Holdings Inc Annual Shareholders Meeting - 1:00PM EDT - Add to calendar
Apr 29, 2016
Q1 2016 Alphatec Holdings Inc Earnings Release (Estimated)
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '16) 2015
Net profit margin -14.78% -96.44%
Operating margin -8.35% -93.07%
EBITD margin - 7.03%
Return on average assets -18.20% -72.74%
Return on average equity - -317.99%
Employees 430 -
CDP Score - -

Address

5818 El Camino Real
CARLSBAD, CA 92008
United States - Map
+1-760-4319286 (Phone)
+1-302-6365454 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

Alphatec Holdings, Inc. is a medical technology company. The Company through its subsidiary, Alphatec Spine, Inc. and its subsidiaries (Alphatec Spine) designs, develops, manufactures and markets products for the surgical treatment of spine disorders. Its product portfolio and pipeline addresses the cervical, thoracolumbar and intervertebral regions of the spine and covers a range of spinal disorders and surgical procedures. Its principal product offerings are focused on the global market for fusion-based spinal disorder solutions. In addition to the United States operations, the Company also markets its products in over 50 international markets through its affiliate, Scient'x S.A.S. and its subsidiaries, through a direct salesforce in Italy and the United Kingdom, and through independent distributors in the rest of Europe, the Middle East and Africa. In South America and Latin America, the Company conducts its operations through its Brazilian subsidiary, Cibramed Productos Medicos.

Officers and directors

James M. Corbett President, Chief Executive Officer, Director
Age: 57
Bio & Compensation  - Reuters
Michael O'Neill Chief Financial Officer, Vice President, Treasurer
Age: 55
Bio & Compensation  - Reuters
Mitsuo Asai President of Alphatec Pacific, Inc.
Age: 60
Bio & Compensation  - Reuters
Michael Plunkett Chief Operating Officer
Age: 57
Bio & Compensation  - Reuters
Ebun S. Garner Esq. Senior Vice President, General Counsel, Corporate Secretary
Age: 43
Bio & Compensation  - Reuters
Kristin Machacek Leary Senior Vice President - Global Human Resources
Age: 46
Bio & Compensation  - Reuters
Stephen A. Lubischer Vice President - Sales
Age: 52
Bio & Compensation  - Reuters
Leslie H. Cross Non-Executive Independent Chairman of the Board
Age: 64
Bio & Compensation  - Reuters
Mortimer Berkowitz III Director
Age: 61
Bio & Compensation  - Reuters
Siri S. Marshall Independent Director
Age: 67
Bio & Compensation  - Reuters